Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 25, 2018Molecular Cancer Therapeutics

Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHui ChenRLRajyalakshmi LuthraMRMark J. Routbort

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chen et al. (2018) studied this question.

synapsesocial.com/papers/6aa70f495069cd445b812900https://doi.org/10.1158/1535-7163.mct-17-0871
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Single thyroid tumour showing multiple differentiated morphological patterns and intramorphological molecular genetic heterogeneity2016 · 18 citations
  2. 2Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers2016 · 1,322 citations
  3. 3Tumor Genotype Determines Phenotype and Disease-related Outcomes in Thyroid Cancer2015 · 138 citations
  4. 4<i>BRAF</i> mutation‐selective inhibition of thyroid cancer cells by the novel MEK inhibitor RDEA119 and genetic‐potentiated synergism with the mTOR inhibitor temsirolimus2010 · 61 citations
  5. 5Next-generation sequencing reveals somatic mutations that confer exceptional response to everolimus2016 · 65 citations